Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Arctigenin enhances the sensitivity of cisplatin resistant colorectal cancer cell by activating autophagy
Yuzhen Wang, Lina Li, Li Xu, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 520, Iss. 1, pp. 20-26
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4002-4002
Open Access | Times Cited: 219
Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics
Yang Yang, Lixia Liu, Yu Tian, et al.
Cancer Letters (2024) Vol. 587, pp. 216659-216659
Open Access | Times Cited: 71
Cancer Drug Resistance: Targeting Proliferation or Programmed Cell Death
Elena V. Sazonova, Maria A. Yapryntseva, Nikolay V. Pervushin, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 388-388
Open Access | Times Cited: 14
Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy
Shuai Guo, Yafei Chen, Sai Shi, et al.
Pharmacological Research (2020) Vol. 155, pp. 104721-104721
Closed Access | Times Cited: 52
Arctigenin, an anti-tumor agent; a cutting-edge topic and up-to-the-minute approach in cancer treatment
Arezoo Gowhari Shabgah, Wanich Suksatan, Muhammad Harun Achmad, et al.
European Journal of Pharmacology (2021) Vol. 909, pp. 174419-174419
Closed Access | Times Cited: 36
Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
Sajad Fakhri, Seyed Zachariah Moradi, Akram Yarmohammadi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 28
Polyphenol-Mediated Autophagy in Cancer: Evidence of In Vitro and In Vivo Studies
Monica Benvenuto, Loredana Albonici, Chiara Focaccetti, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6635-6635
Open Access | Times Cited: 39
Plumbagin Enhances the Anticancer Efficacy of Cisplatin by Increasing Intracellular ROS in Human Tongue Squamous Cell Carcinoma
Danfeng Xue, Shuting Pan, Xiongming Zhou, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-21
Open Access | Times Cited: 37
The Synergism of Natural Compounds and Conventional Therapeutics against Colorectal Cancer Progression and Metastasis
Zimao Liang, Han Xie, Weixing Shen, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 9
Open Access | Times Cited: 20
Combinatorial Effects of the Natural Products Arctigenin, Chlorogenic Acid, and Cinnamaldehyde Commit Oxidation Assassination on Breast Cancer Cells
Caroline Schuster, Nicholas Wolpert, Naïma Moustaïd‐Moussa, et al.
Antioxidants (2022) Vol. 11, Iss. 3, pp. 591-591
Open Access | Times Cited: 19
Phytochemicals Target Multiple Metabolic Pathways in Cancer
Oleg Shuvalov, Yulia Kirdeeva, Alexandra Daks, et al.
Antioxidants (2023) Vol. 12, Iss. 11, pp. 2012-2012
Open Access | Times Cited: 11
Extracellular vesicles containing MFGE8 from colorectal cancer facilitate macrophage efferocytosis
Zhixin Ma, Yu Sun, Yang Yu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Arctigenin Inhibits Glioblastoma Proliferation through the AKT/mTOR Pathway and Induces Autophagy
Yong’An Jiang, Jiayu Liu, Wangwang Hong, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-13
Open Access | Times Cited: 28
Enhancing chemotherapeutic efficacy: Niosome‐encapsulated Dox‐Cis with MUC‐1 aptamer
Fırat Barış Barlas, Bilge Olceroglu, Didem Ag Seleci, et al.
Cancer Medicine (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 3
lncRNA LUNAR1 accelerates colorectal cancer progression by targeting the miR‑495‑3p/MYCBP axis
Jiajie Qian, Alok Garg, Fuqiang Li, et al.
International Journal of Oncology (2020)
Open Access | Times Cited: 24
Glucose oxidase loaded Cu2+ based metal-organic framework for glutathione depletion/reactive oxygen species elevation enhanced chemotherapy
Jinzhi Xu, Yan Xu, Lixin Sun, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111606-111606
Open Access | Times Cited: 21
The therapeutic potential of arctigenin against multiple human diseases: A mechanistic review
Guanming Wang, Ge Li, Tongyu Liu, et al.
Phytomedicine (2023) Vol. 110, pp. 154647-154647
Closed Access | Times Cited: 8
Arctigenin Triggers Apoptosis and Autophagy <i>via</i> PI3K/Akt/mTOR Inhibition in PC-3M Cells
Sun Bai-ling, Enbo Cai, Yan Zhao, et al.
Chemical and Pharmaceutical Bulletin (2021) Vol. 69, Iss. 5, pp. 472-480
Open Access | Times Cited: 19
Targeted Delivery of Arctigenin Using Sialic Acid Conjugate-Modified Liposomes for the Treatment of Breast Cancer
Shunfang Liu, Yaozhen He, Minding Feng, et al.
Molecules (2024) Vol. 29, Iss. 1, pp. 278-278
Open Access | Times Cited: 2
In vitro models to evaluate multidrug resistance in cancer cells: Biochemical and morphological techniques and pharmacological strategies
M Madrid, Eleicy Nathaly Mendoza, A. Padilla, et al.
Journal of Toxicology and Environmental Health Part B (2024), pp. 1-27
Closed Access | Times Cited: 2
Arctigenin Attenuates Breast Cancer Progression through Decreasing GM-CSF/TSLP/STAT3/β-Catenin Signaling
Hui Shi, Luping Zhao, Xinlin Guo, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6357-6357
Open Access | Times Cited: 18
Function and Regulation of the Calcium-Activated Chloride Channel Anoctamin 1 (TMEM16A)
Jorge Arreola, Patricia Pérez‐Cornejo, Guadalupe Segura-Covarrubias, et al.
Handbook of experimental pharmacology (2022), pp. 101-151
Closed Access | Times Cited: 9
Arctigenin hinders the invasion and metastasis of cervical cancer cells via the FAK/paxillin pathway
Dan Liao, Yanyan Liu, Cuifen Li, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e16683-e16683
Open Access | Times Cited: 5
Arctigenin suppresses cell proliferation via autophagy inhibition in hepatocellular carcinoma cells
Shinya Okubo, Tomoe Ohta, Yukihiro Shoyama, et al.
Journal of Natural Medicines (2020) Vol. 74, Iss. 3, pp. 525-532
Closed Access | Times Cited: 12
Arctigenin inhibits human breast cancer cell proliferation, migratory and invasive abilities and epithelial to mesenchymal transition by targeting 4EBP1
Wenfang Luo, Fei Wang, Hewei Luo, et al.
Experimental and Therapeutic Medicine (2021) Vol. 21, Iss. 6
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top